Chinese Journal of Tissue Engineering Research ›› 2015, Vol. 19 ›› Issue (19): 3096-3101.doi: 10.3969/j.issn.2095-4344.2015.19.024
Previous Articles Next Articles
Bai Yu
Online:
2015-05-06
Published:
2015-05-06
About author:
Bai Yu, Master, Physician, First Department of Endocrinology, Shengjing Hospital, China Medical University, Shenyang 110004, Liaoning Province, China
CLC Number:
Bai Yu. Stem cell therapy for type 1 diabetes mellitus [J]. Chinese Journal of Tissue Engineering Research, 2015, 19(19): 3096-3101.
[1] El-Ziny MA, Salem NA, El-Hawary AK, et al. Epidemiology of childhood type 1 diabetes mellitus in Nile Delta, northern Egypt - a retrospective study. J Clin Res Pediatr Endocrinol. 2014;6(1):9-15. [2] van Belle TL, Coppieters KT, von Herrath MG. Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol Rev. 2011;91(1):79-118. [3] Zóka A, Somogyi A, Firneisz G. Type 1 diabetes mellitus: most recent advances in its pathogenesis and treatment. Orv Hetil. 2012;153(27):1047-1056. [4] Patelarou E, Girvalaki C, Brokalaki H, et al. Current evidence on the associations of breastfeeding, infant formula, and cow's milk introduction with type 1 diabetes mellitus: a systematic review. Nutr Rev. 2012;70(9):509-519. [5] Morran MP, Vonberg A, Khadra A, et al. Immunogenetics of type 1 diabetes mellitus. Mol Aspects Med. 2015;42:42-60. [6] Martinez PJ, Mathews C, Actor JK, et al. Impaired CD4+ and T-helper 17 cell memory response to Streptococcus pneumoniae is associated with elevated glucose and percent glycated hemoglobin A1c in Mexican Americans with type 2 diabetes mellitus. Transl Res. 2014;163(1):53-63. [7] Michalek J, Vrabelova Z, Hrotekova Z, et al. Immune regulatory T cells in siblings of children suffering from type 1 diabetes mellitus. Scand J Immunol. 2006;64(5):531-535. [8] Szablewski L. Role of immune system in type 1 diabetes mellitus pathogenesis. Int Immunopharmacol. 2014; 22(1): 182-191. [9] Li M, Song LJ, Qin XY. Advances in the cellular immunological pathogenesis of type 1 diabetes. J Cell Mol Med. 2014;18(5): 749-758. [10] Adamson KA, Cheetham TD, Kendall-Taylor P, et al. The role of the IDDM2 locus in the susceptibility of UK APS1 subjects to type 1 diabetes mellitus. Int J Immunogenet. 2007;34(1): 17-21. [11] Zóka A, Barna G, Somogyi A, et al. Extension of the CD4+Foxp3+CD25-/low regulatory T-cell subpopulation in type 1 diabetes mellitus. Autoimmunity. 2014:1-9. [12] Fridell JA, Rogers J, Stratta RJ. The pancreas allograft donor: current status, controversies, and challenges for the future. Clin Transplant. 2010;24(4):433-449. [13] Krause DS, Theise ND, Collector MI, et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell. 2001;105(3):369-377. [14] Lin PY, Hung SH, Yang YC, et al. A synthetic peptide-acrylate surface for production of insulin-producing cells from human embryonic stem cells. Stem Cells Dev. 2014;23(4):372-379. [15] Kahan BW, Jacobson LM, Hullett DA, et al. Pancreatic precursors and differentiated islet cell types from murine embryonic stem cells: an in vitro model to study islet differentiation. Diabetes. 2003;52(8):2016-2024. [16] Brolén GK, Heins N, Edsbagge J, et al. Signals from the embryonic mouse pancreas induce differentiation of human embryonic stem cells into insulin-producing beta-cell-like cells. Diabetes. 2005;54(10):2867-2874. [17] Kwon YD, Oh SK, Kim HS, et al. Cellular manipulation of human embryonic stem cells by TAT-PDX1 protein transduction. Mol Ther. 2005;12(1):28-32. [18] Xiao X, Chen Z, Shiota C, et al. No evidence for β cell neogenesis in murine adult pancreas. J Clin Invest. 2013; 123(5):2207-2217. [19] Calafiore R, Montanucci P, Basta G. Stem cells for pancreatic β-cell replacement in diabetes mellitus: actual perspectives. Curr Opin Organ Transplant. 2014;19(2):162-168. [20] Szot GL, Yadav M, Lang J, et al. Tolerance induction and reversal of diabetes in mice transplanted with human embryonic stem cell-derived pancreatic endoderm. Cell Stem Cell. 2015;16(2):148-157. [21] Cavelti-Weder C, Shtessel M, Reuss JE, et al. Pancreatic duct ligation after almost complete β-cell loss: exocrine regeneration but no evidence of β-cell regeneration. Endocrinology. 2013;154(12):4493-4502. [22] Lee KO, Gan SU, Calne RY. Stem cell therapy for diabetes. Indian J Endocrinol Metab. 2012;16(Suppl 2):S227-229. [23] Aali E, Mirzamohammadi S, Ghaznavi H, et al. A comparative study of mesenchymal stem cell transplantation with its paracrine effect on control of hyperglycemia in type 1 diabetic rats. J Diabetes Metab Disord. 2014;13(1):76. [24] Mesples A, Majeed N, Zhang Y, et al. Early immunotherapy using autologous adult stem cells reversed the effect of anti-pancreatic islets in recently diagnosed type 1 diabetes mellitus: preliminary results. Med Sci Monit. 2013;19: 852-857. [25] Li M, Ikehara S. Bone-marrow-derived mesenchymal stem cells for organ repair. Stem Cells Int. 2013;2013:132642. [26] Malgieri A, Kantzari E, Patrizi MP, et al. Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art. Int J Clin Exp Med. 2010;3(4):248-269. [27] Trivedi HL, Vanikar AV, Thakker U, et al. Human adipose tissue-derived mesenchymal stem cells combined with hematopoietic stem cell transplantation synthesize insulin. Transplant Proc. 2008;40(4):1135-1139. [28] Pan XH, Song QQ, Dai JJ, et al. Transplantation of bone marrow mesenchymal stem cells for the treatment of type 2 diabetes in a macaque model. Cells Tissues Organs. 2013; 198(6):414-427. [29] Ianus A, Holz GG, Theise ND, et al. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest. 2003; 111(6):843-850. [30] Voltarelli JC, Couri CE, Stracieri AB, et al. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA. 2007;297 (14):1568-1576. [31] Karaoz E, Okcu A, Ünal ZS, et al. Adipose tissue-derived mesenchymal stromal cells efficiently differentiate into insulin-producing cells in pancreatic islet microenvironment both in vitro and in vivo. Cytotherapy. 2013;15(5):557-570. [32] Teichert AM, Pereira S, Coles B, et al. The neural stem cell lineage reveals novel relationships among spermatogonial germ stem cells and other pluripotent stem cells. Stem Cells Dev. 2014;23(7):767-778. [33] Morimoto H, Iwata K, Ogonuki N, et al. ROS are required for mouse spermatogonial stem cell self-renewal. Cell Stem Cell. 2013;12(6):774-786. [34] Guo XR, Wang XL, Li MC, et al. PDX-1 mRNA-induced reprogramming of mouse pancreas-derived mesenchymal stem cells into insulin-producing cells in vitro. Clin Exp Med. 2014 Oct 28. [Epub ahead of print] [35] Godfrey KJ, Mathew B, Bulman JC, et al. Stem cell-based treatments for Type 1 diabetes mellitus: bone marrow, embryonic, hepatic, pancreatic and induced pluripotent stem cells. Diabet Med. 2012;29(1):14-23. [36] Li SW, Koya V, Li Y, et al. Pancreatic duodenal homeobox 1 protein is a novel beta-cell-specific autoantigen for type I diabetes. Lab Invest. 2010;90(1):31-39. [37] Ende N, Chen R, Reddi AS. Effect of human umbilical cord blood cells on glycemia and insulitis in type 1 diabetic mice. Biochem Biophys Res Commun. 2004;325(3):665-669. [38] Haller MJ, Viener HL, Wasserfall C, et al. Autologous umbilical cord blood infusion for type 1 diabetes. Exp Hematol. 2008;36(6):710-715. [39] BarNur O, Russ HA, Efrat S, et al. Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. Cell Stem Cell. 2011;9(1):17-23. [40] Kuise T, Noguchi H, Tazawa H, et al. Establishment of a pancreatic stem cell line from fibroblast-derived induced pluripotent stem cells. Biomed Eng Online. 2014;13:64. [41] Zavazava N. Progress toward establishing embryonic stem or induced pluripotent stem cell-based clinical translation. Curr Opin Organ Transplant. 2014;19(6):598-602. [42] Golestaneh N, Kokkinaki M, Pant D, et al. Pluripotent stem cells derived from adult human testes. Stem Cells Dev. 2009; 18(8):1115-1126. |
[1] | Chen Xiao, Guo Zhi, Chen Lina, Liu Xuanyong, Zhang Yihuizhi, Li Xumian, Wang Yueqiao, Wei Liya, Xie Jing, Lin Li. Factors affecting the mobilization and collection of autologous peripheral blood hematopoietic stem cells [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(19): 2958-2962. |
[2] | Sun Weixing, Zhao Yongchao, Zhao Ranzun. Mesenchymal stem cell transplantation in the treatment of myocardial infarction: problems, crux and new breakthrough [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(19): 3103-3109. |
[3] | Cao Linlin, Ding Kaiyang, Song Hao, Wu Guolin, Hu Maogui, Fan Dandan, Zhou Chenyang, Wang Cuicui, Feng Yuanyuan. Efficacy and influencing factors of autologous hematopoietic stem cell transplantation in the treatment of malignant lymphoma [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(13): 1993-1998. |
[4] | Zhang Wenjian, Ma Lingfu, Wang Zhimin, Mo Wenjian, Zhou Ruiqing. Muscle mass evaluation and influencing factors of sarcopenia in allogeneic hematopoietic stem cell transplantation patients [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(13): 1999-2004. |
[5] | Zhang Suping, Sun Ling, Wan Dingming, Cao Weijie, Li Li, Liu Changfeng, Liu Yufeng, Wang Dao, Guo Rong, Jiang Zhongxing, Xie Xinsheng. Effectiveness of unrelated peripheral blood stem cell transplantation in the treatment of severe aplastic anemia [J]. Chinese Journal of Tissue Engineering Research, 2020, 24(31): 4994-5001. |
[6] |
Feng Yuan, Han Zhiqi, Zhou Nuo.
Endothelial progenitor cells promote vasculogenesis and osteogenesis in the repair of bone defects [J]. Chinese Journal of Tissue Engineering Research, 2020, 24(25): 4046-4053. |
[7] | Wei Yuanfeng, Huang Dongping. Current status of hematopoietic stem cell transplantation in the treatment of aplastic anemia [J]. Chinese Journal of Tissue Engineering Research, 2020, 24(19): 3093-3100. |
[8] | Zhang Ling, Sun Yanling, Wang Xiaozhen, Long Bing , Liu Jiajun. Umbilical cord mesenchymal stem cells for the treatment of refractory chronic graft-versus-host disease [J]. Chinese Journal of Tissue Engineering Research, 2020, 24(13): 2034-2038. |
[9] | Zhang Jingyi, Hai Guodong, Yang Haofei, Fan Congliang, Yan Lei, Zhang Chunlei, Dou Junfeng, Ma Hailong. Changes in serum levels of fibroblast growth factor-2, hypoxia-inducible factor-1alpha and vascular endothelial growth factor in patients with avascular necrosis of femoral head treated by enriched autologous bone marrow stem cell transplantation combined with core decompression [J]. Chinese Journal of Tissue Engineering Research, 2020, 24(1): 14-14. |
[10] | Sun Heyuan, Yan Weiqing. Adipose-derived stem cell transplantation for acute kidney injury caused by crush injury [J]. Chinese Journal of Tissue Engineering Research, 2019, 23(9): 1364-1369. |
[11] | Wang Yifei, Song Yang, Guan Yongge, Xu Chunyan. Bone marrow mesenchymal stem cell transplantation in a rat model of thin endometrium based on HOXA10 regulatory network [J]. Chinese Journal of Tissue Engineering Research, 2019, 23(9): 1397-1402. |
[12] | Zhang Deguo, Tan Xueying, Tang Nan, Huang Fei, Shi Guangjun. Human adipose-derived mesenchymal stem cell transplantation via the tail vein for acute liver failure in rats [J]. Chinese Journal of Tissue Engineering Research, 2019, 23(9): 1416-1421. |
[13] | Liu Meilin, Fu Songtao, Wang Peisen, Hao Ran, Chang Bingmei, Hou Xiuying. Liposome prepared from human umbilical cord mesenchymal stem cell conditioned medium for repair of skin wound in rats [J]. Chinese Journal of Tissue Engineering Research, 2019, 23(5): 734-740. |
[14] | Feng Fang, Dong Chenming, Chen Yu, Qi Yan. Adipose tissue-derived mesenchymal stem cell transplantation for treating septic rats with acute respiratory distress syndrome and the underlying mechanism [J]. Chinese Journal of Tissue Engineering Research, 2019, 23(5): 741-748. |
[15] | Xue Hui, Feng Shuqing, Hu Yongchao, Liu Zhibin, Li Xiaoyu, Gao Feng. Stratification therapy for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation [J]. Chinese Journal of Tissue Engineering Research, 2019, 23(5): 756-760. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||